Fabio Sangalli - Concepedia

Concepedia

Author

Fabio Sangalli

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

F Sangalli, F. Sangalli, Fabio Sangalli, Sangalli, Fabio

50

Publications

2.2K

Citations

26

H-Index

61

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research University of Bergamo Azienda Ospedaliero Universitaria Ospedali Riuniti Istituti di Ricovero e Cura a Carattere Scientifico Politecnico di Milano

FS

About

Fabio Sangalli is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	1.9K
2	Health Sciences	2	2	144
3	Cell Biology	2	2	292
4	Engineering	1	1	197
5	Biomedical Engineering	1	1	197

Fabio Sangalli

×

31

Publications

2.2K

Citations

26

H-Index

	Year	Citations
Recellularization of Well-Preserved Acellular Kidney Scaffold Using Embryonic Stem Cells Barbara Bonandrini, Marina Figliuzzi, Evangelia Papadimou, Tissue Engineering Part A Tissue EngineeringEngineeringCollagen IvAdult Stem CellBiofabrication	2013	197
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies Ruth Campbell, Fabio Sangalli, Elena Perticucci, Kidney International GlomerulonephritisHypertensionUrologyRheumatologyRenal Function	2003	186
Pathophysiologic Implications of Reduced Podocyte Number in a Rat Model of Progressive Glomerular Injury Daniela Macconi, Maria Bonomelli, Ariela Benigni, American Journal Of Pathology Glomerular DiseaseGlomerulonephritisInflammationRenal FunctionProgressive Glomerular Injury	2006	144
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes Elena Gagliardini, Daniela Corna, Carla Zoja, American Journal of Physiology-Renal Physiology Renal FunctionRenal LesionsChronic Kidney DiseasePharmacologyDiabetes	2009	123
ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease Andrea Remuzzi, Elena Gagliardini, Fabio Sangalli, Kidney International Glomerular DiseaseGlomerulonephritisUrologyRenal DiseaseRenal Function	2006	116
Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. Norberto Perico, Andrea Remuzzi, Fabio Sangalli, Journal of the American Society of Nephrology UrologyAngiotensin IiRenal FunctionFicoll Fractional ClearanceMedicine	1996	108
ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy Andrea Remuzzi, Norberto Perico, Fabio Sangalli, American Journal of Physiology-Renal Physiology Glomerular DiseaseHypertensionAce InhibitionRenal PathologyImmunology	1999	106
Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficit. Annamaria Fassi, Fabio Sangalli, Raffaello Maffi, Journal of the American Society of Nephrology Glomerular DiseaseHypertensionRenal PathologyGlomerulonephritisRenal Function	1998	101
Podocyte Repopulation Contributes to Regression of Glomerular Injury Induced by Ace Inhibition Daniela Macconi, Fabio Sangalli, Maria Bonomelli, American Journal Of Pathology Glomerular DiseaseAce InhibitionImmunologyOxidative StressInflammation	2009	100
Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects Carla Zoja, Daniela Corna, Valeria Nava, American Journal of Physiology-Renal Physiology Additional Adverse EffectsRenal InflammationBardoxolone AnalogsOxidative StressGlomerulonephritis	2012	99

Page 1